Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00063934
Status:
TERMINATED
Last Update Posted:
2019-03-05
First Post:
2003-07-08
Brief Title:
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Breast Cancer |
| Male Breast Cancer |
| Stage IIIA Breast Cancer |
| Stage IIIB Breast Cancer |
| Stage IIIC Breast Cancer |
Keywords: